Hui Sun to Cost-Benefit Analysis
This is a "connection" page, showing publications Hui Sun has written about Cost-Benefit Analysis.
Connection Strength
0.124
-
Bansback N, Phibbs CS, Sun H, O'Dell JR, Brophy M, Keystone EC, Leatherman S, Mikuls TR, Anis AH. Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis. Ann Intern Med. 2017 07 04; 167(1):8-16.
Score: 0.124